- Home
- ABOS vs FCCO Comparison
ABOS vs FCCO Comparison
Compare ABOS & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABOS
- FCCO
- Stock Information
- Founded
- ABOS 1996
- FCCO 1994
- Country
- ABOS United States
- FCCO United States
- Employees
- ABOS N/A
- FCCO N/A
- Industry
- ABOS Biotechnology: Pharmaceutical Preparations
- FCCO Major Banks
- Sector
- ABOS Health Care
- FCCO Finance
- Exchange
- ABOS Nasdaq
- FCCO Nasdaq
- Market Cap
- ABOS 84.2M
- FCCO 190.8M
- IPO Year
- ABOS 2021
- FCCO 1998
- Fundamental
- Price
- ABOS $1.23
- FCCO $28.16
- Analyst Decision
- ABOS Strong Buy
- FCCO Strong Buy
- Analyst Count
- ABOS 3
- FCCO 2
- Target Price
- ABOS $8.00
- FCCO $30.00
- AVG Volume (30 Days)
- ABOS 182.5K
- FCCO 20.6K
- Earning Date
- ABOS 11-11-2025
- FCCO 10-22-2025
- Dividend Yield
- ABOS N/A
- FCCO 2.29%
- EPS Growth
- ABOS N/A
- FCCO 57.01
- EPS
- ABOS N/A
- FCCO 2.23
- Revenue
- ABOS N/A
- FCCO $71,913,000.00
- Revenue This Year
- ABOS N/A
- FCCO $21.83
- Revenue Next Year
- ABOS N/A
- FCCO $28.41
- P/E Ratio
- ABOS N/A
- FCCO $12.56
- Revenue Growth
- ABOS N/A
- FCCO 21.39
- 52 Week Low
- ABOS $0.86
- FCCO $19.46
- 52 Week High
- ABOS $3.36
- FCCO $28.77
- Technical
- Relative Strength Index (RSI)
- ABOS 39.55
- FCCO 72.97
- Support Level
- ABOS $1.34
- FCCO $27.84
- Resistance Level
- ABOS $1.47
- FCCO $28.77
- Average True Range (ATR)
- ABOS 0.08
- FCCO 0.41
- MACD
- ABOS -0.02
- FCCO 0.01
- Stochastic Oscillator
- ABOS 7.69
- FCCO 63.91
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About FCCO First Community Corporation
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.